论文部分内容阅读
近年来,卵巢癌的发病率呈现上升趋势,约占妇科恶性肿瘤的 25%,并且卵巢癌的发病早期经常无明显的临床表现,而已经发现均为晚期,因此,早期发现,早期治疗,非常关键。肿瘤标志物CA125是卵巢肿瘤细胞的表面相关抗原,对卵巢恶性肿瘤的早期诊断、疗效评价及预后观察非常有价值,但
In recent years, the incidence of ovarian cancer showed an upward trend, accounting for about 25% of gynecological malignancies, and the early onset of ovarian cancer often have no obvious clinical manifestations, but have been found late, therefore, early detection, early treatment, very The essential. Tumor marker CA125 is a surface-associated antigen in ovarian tumor cells and is valuable for the early diagnosis, efficacy evaluation and prognosis of ovarian cancer